Mechanisms in the bed nucleus of the stria terminalis involved in control of autonomic and neuroendocrine functions: A review

dc.contributor.authorCrestani, Carlos Cesar [UNESP]
dc.contributor.authorAlves, Fernando H. F.
dc.contributor.authorGomes, Felipe V.
dc.contributor.authorResstel, Leonardo B. M.
dc.contributor.authorCorrea, Fernando M. A.
dc.contributor.authorHerman, James P.
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionMetabolic Diseases Institute
dc.date.accessioned2014-05-27T11:29:00Z
dc.date.available2014-05-27T11:29:00Z
dc.date.issued2013-04-30
dc.description.abstractThe bed nucleus of the stria terminalis (BNST) is a heterogeneous and complex limbic forebrain structure, which plays an important role in controlling autonomic, neuroendocrine and behavioral responses. The BNST is thought to serve as a key relay connecting limbic forebrain structures to hypothalamic and brainstem regions associated with autonomic and neuroendocrine functions. Its control of physiological and behavioral activity is mediated by local action of numerous neurotransmitters. In the present review we discuss the role of the BNST in control of both autonomic and neuroendocrine function. A description of BNST control of cardiovascular and hypothalamus-pituitary-adrenal axisactivity at rest and during physiological challenges (stress and physical exercise) is presented. Moreover, evidence for modulation of hypothalamic magnocellular neurons activity is also discussed. We attempt to focus on the discussion of BNST neurochemical mechanisms. Therefore, the source and targets of neurochemical inputs to BNST subregions and their role in control of autonomic and neuroendocrine function is discussed in details. © 2013 Bentham Science Publishers.en
dc.description.affiliationLaboratory of Pharmacology, Department of Natural Active Principles and Toxicology School of Pharmaceutical Sciences São Paulo State University, UNESP, Rodovia Araraquara-Jau Km 01 (Campus Universitário), Araraquara, SP, 14801-902
dc.description.affiliationDepartment of Pharmacology School of Medicine of Ribeirão Preto University of São Paulo, Ribeirão Preto, SP, 14049-900
dc.description.affiliationDepartment of Psychiatry and Behavioral Neuroscience University of Cincinnati Metabolic Diseases Institute, Cincinnati, OH, 45237-0506
dc.description.affiliationUnespLaboratory of Pharmacology, Department of Natural Active Principles and Toxicology School of Pharmaceutical Sciences São Paulo State University, UNESP, Rodovia Araraquara-Jau Km 01 (Campus Universitário), Araraquara, SP, 14801-902
dc.description.sponsorshipFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
dc.description.sponsorshipConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
dc.description.sponsorshipPADC-UNESP
dc.description.sponsorshipFundação para o Desenvolvimento da UNESP (FUNDUNESP)
dc.description.sponsorshipIdFAPESP: 10/16192-8
dc.description.sponsorshipIdCNPq: 474177/2010-6
dc.format.extent141-159
dc.identifierhttp://dx.doi.org/10.2174/1570159X11311020002
dc.identifier.citationCurrent Neuropharmacology, v. 11, n. 2, p. 141-159, 2013.
dc.identifier.doi10.2174/1570159X11311020002
dc.identifier.issn1570-159X
dc.identifier.issn1875-6190
dc.identifier.lattes1117432571971568
dc.identifier.scopus2-s2.0-84876707420
dc.identifier.urihttp://hdl.handle.net/11449/75192
dc.identifier.wosWOS:000317845300002
dc.language.isoeng
dc.relation.ispartofCurrent Neuropharmacology
dc.relation.ispartofjcr4.068
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectBNST
dc.subjectCardiovascular function
dc.subjectExtended amygdala
dc.subjectHPA axis
dc.subjectNeurotransmitters
dc.subjectStress and physical exercise
dc.subjectVasopressin
dc.subject2 (2 methoxy 1, 4 benzodioxan 2 yl) 2 imidazoline
dc.subject2 (2 methoxy 1,4 benzodioxan 2 yl) 2 imidazoline
dc.subject2 [[2 (2, 6 dimethoxyphenoxy) ethyl] aminomethyl] 1, 4 benzodioxan
dc.subject2 [[2 (2,6 dimethoxyphenoxy)ethyl]aminomethyl] 1,4 benzodioxan
dc.subject4 aminobutyric acid
dc.subject5 [2 [[2 hydroxy 3 [4 (1 methyl 4 trifluoromethyl 2 imidazolyl) phenoxy] propyl] amino] ethoxy] salicylamide
dc.subject5 [2 [[2 hydroxy 3 [4 (1 methyl 4 trifluoromethyl 2 imidazolyl)phenoxy]propyl]amino]ethoxy]salicylamide
dc.subjectacetylcholine
dc.subjectbicuculline methiodide
dc.subjectcannabidiol
dc.subjectcarbachol
dc.subjectcobalt chloride
dc.subjectcorticotropin releasing factor
dc.subjectdecahydro 6 phosphonomethyl 3 isoquinolinecarboxylic acid
dc.subjectglutamic acid
dc.subjectmuscimol
dc.subjectneurotransmitter
dc.subjectnitric oxide
dc.subjectnoradrenalin
dc.subjectoxytocin
dc.subjectunclassified drug
dc.subjectvasopressin
dc.subjectarterial pressure
dc.subjectautonomic nervous system
dc.subjectbehavior
dc.subjectblood pressure
dc.subjectbrain stem
dc.subjectchemoreceptor reflex
dc.subjectdynamic exercise
dc.subjectelectrostimulation
dc.subjectexercise
dc.subjectfear
dc.subjectforebrain
dc.subjecthuman
dc.subjecthypothalamus
dc.subjectimmobilization stress
dc.subjectmagnocellular nucleus
dc.subjectmicrodialysis
dc.subjectnerve conduction
dc.subjectneuroendocrine system
dc.subjectneurotransmission
dc.subjectnonhuman
dc.subjectphysiological process
dc.subjectpressoreceptor
dc.subjectreview
dc.subjectstria terminalis
dc.titleMechanisms in the bed nucleus of the stria terminalis involved in control of autonomic and neuroendocrine functions: A reviewen
dc.typeResenha
dcterms.licensehttp://eurekaselect.com/209
unesp.author.lattes1117432571971568[1]
unesp.author.orcid0000-0003-3571-2406[6]
unesp.author.orcid0000-0002-1942-858X[1]
unesp.author.orcid0000-0003-4067-9524[5]
unesp.author.orcid0000-0003-1033-1850[3]
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentPrincípios Ativos Naturais e Toxicologia - FCFpt

Arquivos